Diffuse fibrosis, nodule development, and loss of the hepatic parenchyma are the hallmarks of cirrhosis of the liver (CP), a chronic progressive illness that causes portal hypertension and hepatic failure. The illness is linked to a high rate of morbidity and death globally and is the last stage of many chronic liver illnesses. The origin, pathophysiology, clinical signs, diagnostic methods, therapeutic modalities, and prognosis of liver cirrhosis are all thoroughly covered in this article. The significance of early diagnosis and multidisciplinary care is emphasized in order to avoid consequences such hepatocellular cancer, ascites, variceal hemorrhage, and hepatic encephalopathy.

Cirrhosis of the liver, fibrosis, portal hypertension

World Health Organization. Global Health Estimates 2023: Disease Burden by Cause, Age, Sex, by Country and by Region, 2000–2022. Geneva: WHO; 2023.

European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B and C. J Hepatol. 2020;73(1):117–144.

Gao B, Bataller R. Alcoholic liver disease: Pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572–1585.

Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655–1669.

Kisseleva T, Brenner DA. Mechanisms of fibrogenesis. Exp Biol Med. 2008;233(2):109–122.

D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review. J Hepatol. 2006;44(1):217–231.